A Clinical Study of MK-8294 in Participants With Advanced Solid Tumors (MK-8294-001)
- Status
- RECRUITING
- Phase
- PHASE1
Clinical Trials Related to Merck Sharp & Dohme LLC
Related studies linked through entity extraction aliases.
Neoadjuvant ADT + Darolutamide With Pembrolizumab, Followed by Adjuvant Pembrolizumab in Molecularly Stratified High-Risk Prostate Cancer
- Status
- RECRUITING
- Phase
- PHASE2
A Clinical Study of MK-8527 in Participants With Mild and Moderate Hepatic Impairment (MK-8527-015)
- Status
- COMPLETED
- Phase
- PHASE1
An Open Label Phase 2 Study of Total Neoadjuvant Therapy (TNT) Consisting of FLOT With Pembrolizumab and Short Radiation for Patients With Locally Advanced Gastroesophageal Junction Adenocarcinoma
- Status
- RECRUITING
- Phase
- PHASE2
ASTRAEA: ReinvigorAting ReSponse To ImmunotheRApy in MEtAstatic TNBC With Combination Myeloid Inhibition and Radiation
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
A Study to Evaluate V181 Dengue Vaccine in Healthy Participants 2 to 17 Years of Age (V181-005/MOBILIZE-1)
- Status
- RECRUITING
- Phase
- PHASE3
Study of Lenvatinib Plus Pembrolizumab in IO Refractory mRCC Patients With Brain Metastases
- Status
- WITHDRAWN
- Phase
- PHASE2
Pembrolizumab for Advanced Cutaneous Sarcomas Not Including Angiosarcoma
- Status
- RECRUITING
- Phase
- PHASE2
A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)
- Status
- RECRUITING
- Phase
- PHASE3
A Study of MK-5684 in People With Certain Solid Tumors (MK-5684-015/OMAHA-015)
- Status
- RECRUITING
- Phase
- PHASE2
Pembrolizumab + Paclitaxel +/- Bevacizumab for Triple-negative Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE2
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
- Status
- RECRUITING
- Phase
- PHASE3
A Clinical Study of Intismeran Autogene (V940) and Pembrolizumab (MK-3475) in People With Melanoma (V940-012/INTerpath-012)
- Status
- RECRUITING
- Phase
- PHASE2
Improving Lipid Optimization Quality and Treatment Options in ASCVD
- Status
- ENROLLING_BY_INVITATION
- Phase
- NA
Study to Evaluate Tulisokibart for Hidradenitis Suppurativa (MK-7240-012)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)
- Status
- RECRUITING
- Phase
- PHASE3
A Study to Evaluate the Effect of Formulation and Food on Calderasib (MK-1084) in Healthy Adult Participants (MK-1084-011)
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Patritumab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01C/LIGHTBEAM-U01)
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Study of Sotatercept (MK-7962) in Healthy Females Administered as a Liquid Formulation in an Autoinjector Versus the Lyophilized Formulation (MK-7962-027)
- Status
- COMPLETED
- Phase
- PHASE1
Interpersonal Communication Training and Vaccination Workflow Training Alone and in Combination to Improve Communication and Recommendations About HPV Vaccination in Pharmacies, IMPACT HPV Trial
- Status
- NOT_YET_RECRUITING
- Phase
- NA